Clinical efficacy of tacrolimus in rosacea

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 2, 2009, Pages 239-240

  Garg, G ^a   Thami, G P ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; STEROID; TACROLIMUS;

CLINICAL FEATURE; DISEASE DURATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; ERYTHEMA; HUMAN; LETTER; PRIORITY JOURNAL; ROSACEA; TELANGIECTASIA; TREATMENT RESPONSE;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; ROSACEA; TACROLIMUS;

EID: 58449090925     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02822.x     Document Type: Letter

References (6)

1. Wilkin J, Dahl M, Detmar M et al. Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 2002 46 : 584 587.
2. Goldman D. Tacrolimus ointment for the treatment of steroid induced rosacea: a preliminary report. J Am Acad Dermatol 2001 44 : 995 998.
3. Gupta AK, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol 2002 16 : 100 114.
4. Ruzicka R, Assman T, Homey B. Tacrolimus: the drug for the millennium? Arch Dermatol 1999 135 : 574 580.
5. Meshkinpour A, Joannie S, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 2003 49 : 145 147.
6. Bamford JT, Elliot BA, Haller IV. Tacrolimus effect on rosacea. J Am Acad Dermatol 2004 50 : 107 108.